Project Details
| Acronym | EBX-Antibiot |
|---|---|
| Status | Active |
| Effective start/end date | 1/04/2022 → 30/11/2025 |
Collaborative partners
- King's College London
- PUBLIC HEALTH ENGLAND (lead)
Funding
- MRC Medical Research Council: £413,512.47
Developing a new class of antibiotics based on Efflux Resistant 4-oxoquinolizines for Multiple Drug-Resistant ESKAPE Pathogens
- Rahman, Miraz (Primary Investigator)
- Amison, Richard (Co-Investigator)
Project: Research